According to report published by International Diabetes Federation (IDF) (the 6th edition of IDF Atlas published in November, 2013) the number of diabetic patients is about 65 million in the country. The data available from the Indian Council of Medical Research, India Diabetes (INDIAB) Study estimates the number to be 62.4 million approximately. Government of … Read more
As per the Indian Council of Medical Research (ICMR) report entitled “Assessment of burden of Non-Communicable Diseases 2006”, the prevalence of diabetes in the age group of 30 to 89 was ranging from 26 to 200 per 1000 in Urban females and 78 to 333 per 1000 in Urban Males. In rural areas, it was … Read more
More than six out of ten people with diabetes are walking around in the wrong-sized shoes, exposing themselves to serious foot problems that could lead to amputation, according to research in the November issue of IJCP, the International Journal of Clinical Practice.
The Indian Government is launching a special programme next month for control and prevention of diabetes, a silent killer worldwide. The National Programme for Prevention of Diabetes and Cardiovascular Diseases will concentrate on spreading awareness about the disease and screen people for the life-threatening disease, Health Minister Anbumani Ramadoss said at a press conference here today.
A protein in the pancreas is giving researchers at the Stanford University School of Medicine their first chance at cracking the code that determines how diabetes develops during pregnancy, a finding that could lead to new treatments for all forms of diabetes.
The shortage of islet cells limits the development of islet transplantation. One new approach was reported in the October 21 issue of the World Journal of Gastroenterology because of its great significance in enhancing the output of islet cells. This article will undoubtedly bring benefit to diabetic patients.
GlaxoSmithKline confirms that the EMEA’s Committee for Medicinal Products for Human Use(CHMP) has completed its benefit risk review of the Thiazolidinediones (TZD) class and have concluded that the benefits of rosiglitazone continue to outweigh the risks.
Some individuals with type 2 diabetes (which is characterized by abnormally high blood glucose levels) have lower than normal amounts of the protein PGC-1-alpha in their skeletal muscles, but it is not known whether this has a role in the onset of diabetes or if it is caused by the diabetes.
The International Diabetes Federation (IDF) has published new guidelines on the contribution and impact of post-meal glucose in diabetes disease management at the 43rd Annual Meeting of the European Association for the Study of Diabetes (EASD) on September_19, 2007. The IDF recognises the growing evidence that post-meal glucose is a key contributor to overall glycaemic control – particularly with respect to HbA1C levels, and that reducing post-meal glucose has a significant impact on the risk of developing diabetic complications.
Researchers are now one step closer to improved treatment of Type 2 diabetes following significant findings made by scientists at the Garvan Institute of Medical Research.